Lisa H. Miller

LISA MILLER represents companies, boards, executives, and other individuals in high-stakes criminal, civil, and regulatory matters. Drawing on more than a decade of experience at the U.S. Department of Justice (DOJ), including as a senior leader of DOJ’s Criminal Division, Lisa guides clients through DOJ investigations, parallel civil and criminal enforcement matters, internal investigations, compliance challenges, congressional inquiries, and crisis situations. She has particular experience advising healthcare and life sciences companies facing government scrutiny and she represents clients across a broad range of industries, including financial services, energy, retail, and technology.

“Lisa is a rock star, I consider her to be a rising practitioner in the white-collar bar.”
Chambers USA 2026

Prior to joining Sidley, Lisa served across political administrations at DOJ and most recently was a Deputy Assistant Attorney General for DOJ’s Criminal Division, the third highest rank in the Division. As Deputy Assistant Attorney General, Lisa oversaw the Criminal Division’s Fraud Section and Appellate Section. In that role, Lisa was responsible for critical decision-making in some of DOJ’s highest profile white-collar and cross-border matters against corporations and individuals. Her portfolio included matters involving the Foreign Corrupt Practices Act (FCPA), trade fraud, securities fraud, and health care fraud cases. She supervised more than 210 attorneys litigating and investigating complex matters nationwide, working alongside U.S. Attorneys’ Offices and other federal and state agencies.

Lisa previously served in top career leadership roles in the Fraud Section’s two largest litigating units, including as Chief of the Market Integrity and Major Frauds Unit and as Principal Assistant Deputy Chief of the Health Care Fraud Unit — the precursor to DOJ’s National Fraud Enforcement Division’s Health Care Fraud Section. Before that, Lisa was an Assistant United States Attorney for the Southern District of Florida in Miami and a Trial Attorney in the Fraud Section’s Health Care Fraud Unit based in Washington, D.C.

Lisa has deep experience with complex financial crimes, including healthcare fraud, kickback, and parallel False Claims Act matters; opioid related matters; the Foreign Corrupt Practices Act; and matters involving money laundering, securities, commodities, accounting and investment fraud, mail and wire fraud, market manipulation, trade fraud, cryptocurrency, procurement fraud, tax fraud, and other forms of government program fraud. She played a central role in developing DOJ-wide policies and practices relevant to corporate criminal enforcement, including the Criminal Division’s Corporate Whistleblower Awards Pilot Program, Corporate Enforcement and Voluntary Self-Disclosure Policy, and Evaluation of Corporate Compliance Programs. Lisa also developed and maintains extensive relationships with domestic and foreign law enforcement and regulatory agencies, including the SEC, CFTC, FBI, HHS-OIG, FDIC-OIG, DEA, HSI, the UK’s Serious Fraud Office and Financial Conduct Authority, the Swiss Office of the Attorney General, France’s Parquet National Financier, and others.

Lisa is a frequent speaker on white-collar enforcement, corporate compliance, and trial work, and has lectured on white-collar crime and prosecution at the University of Virginia School of Law, Yale Law School, and American University.

Lisa received her B.A. cum laude from Cornell University and her J.D. from the University of Virginia School of Law. Prior to her service at DOJ, she clerked for Hon. Edgardo Ramos on the U.S. District Court for the Southern District of New York and was a litigator at another Am Law 50 firm.

Lisa’s vast experience and knowledge has earned her the following recognitions:

• Chambers USA for Litigation: White-Collar Crime & Government Investigations (District of Columbia, 2026);
• Global Investigation Review’s Top 100 Women in Investigations (2025);
• The Attorney General’s Award for Asset Forfeiture (2025);
• The Attorney General’s Award for Distinguished Service (2021);
• The Executive Office for United States Attorneys Director’s Award for Superior Performance by a Litigative Team (2023);
• Criminal Division Assistant Attorney General’s Award for Exceptional Service (2020);
• United States Secret Service Director’s Award (2018);
• United States Department of Health and Human Services, Office of the Inspector General’s Award for Advancing Excellence and Innovation (2018); and
• National Healthcare Anti-Fraud Association Award (2017).

A sampling of Lisa’s representative matters includes:

• Secured early termination of corporate probation in Clean Air Act matter for leading aftermarket automotive company in United States v. Rudy’s Performance Parts, Inc.
• Secured non-public criminal declination from DOJ for a medical device company in a parallel civil and criminal investigation involving suspected violations of the Food Drug and Cosmetic Act (pending).
• Defending an energy company in a DOJ criminal investigation involving allegations of regulatory deceit (pending).
• Representing a financial services company in a DOJ investigation involving money laundering and sanctions evasion.
• Representing numerous former employees and executives of a publicly-traded healthcare company in a federal criminal DOJ investigation and a parallel civil investigation involving allegations of materially false representations to government entities.
• Representing numerous individuals in DOJ investigations involving allegations of wire fraud, money laundering, and tax offenses (pending).
• Defending a privately-held healthcare company in a parallel civil False Claims Act and criminal healthcare fraud DOJ investigation involving allegations of, among other issues, fraudulent cost report submissions (pending).
• Leading an internal investigation for and defending a multinational, publicly-traded healthcare company in a parallel civil and criminal investigation that requires evaluation of cGMP regulations and careful analysis of compliance with FDA standards and representations made to the government, including to the FDA, CMS, and DOD (pending).
• On behalf of a worldwide leader in specialized diagnostics, led an internal investigation involving potential FCPA violations/improper payments to local authorities in a high-risk jurisdiction.
• Advising a public company on congressional investigations related strategy and preparation.
• Counseling a non-profit organization on numerous crisis management issues and congressional investigations (pending).
• Representing multiple corporations victimized by fraud offenses and advising on reports to DOJ and other federal agencies regarding the nature of such offenses and recommended remediation (pending).
• Representing multiple corporate clients on strategies for handling state and federal probes related to alleged unfair/deceptive practices (pending).
• Defending a major national food company in a probe led by a State Attorney General.
• Counseled multiple financial institutions and financial services companies on cannabis related diligence and risks associated with specific transactions.

• Edward Bennett Williams American Inn of Court
• Women's White Collar Defense Association